======= MPDU1 ======= == Gene Information == * **Official Symbol**: MPDU1 * **Official Name**: mannose-P-dolichol utilization defect 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9526|9526]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75352|O75352]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MPDU1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MPDU1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604041|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an endoplasmic reticulum membrane protein that is required for utilization of the mannose donor mannose-P-dolichol in the synthesis of lipid-linked oligosaccharides and glycosylphosphatidylinositols. Mutations in this gene result in congenital disorder of glycosylation type If. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2008]. * **UniProt Summary**: Required for normal utilization of mannose-dolichol phosphate (Dol-P-Man) in the synthesis of N-linked and O-linked oligosaccharides and GPI anchors. {ECO:0000250}. |PQ-loop| |oligosaccharide biosynthetic process| |dolichol-linked oligosaccharide biosynthetic process| |oligosaccharide-lipid intermediate biosynthetic process| |oligosaccharide metabolic process| |protein N-linked glycosylation| |carbohydrate biosynthetic process| |protein folding| |macromolecule glycosylation| |protein glycosylation| |glycosylation| |glycoprotein biosynthetic process| |glycoprotein metabolic process| |carbohydrate metabolic process| |carbohydrate derivative biosynthetic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |carbohydrate derivative metabolic process| |lipid metabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp458|Bisphenol S 100μM R08 exp458]]|-2.38| |[[:results:exp83|Trametinib 10μM R02 exp83]]|-2.29| |[[:results:exp111|R-DABN 8μM R03 exp111]]|1.72| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.77| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|1.94| ^Gene^Correlation^ |[[:human genes:d:dpm3|DPM3]]|0.531| |[[:human genes:d:dpm1|DPM1]]|0.49| |[[:human genes:a:alg6|ALG6]]|0.474| |[[:human genes:m:mbtps2|MBTPS2]]|0.468| |[[:human genes:a:alg9|ALG9]]|0.468| |[[:human genes:s:sec62|SEC62]]|0.451| |[[:human genes:s:sec63|SEC63]]|0.44| |[[:human genes:a:alg8|ALG8]]|0.435| |[[:human genes:a:alg3|ALG3]]|0.427| |[[:human genes:m:mbtps1|MBTPS1]]|0.425| |[[:human genes:s:srd5a3|SRD5A3]]|0.419| |[[:human genes:m:manf|MANF]]|0.416| |[[:human genes:a:alg12|ALG12]]|0.411| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2172 * **Expression level (log2 read counts)**: 5.3 {{:chemogenomics:nalm6 dist.png?nolink |}}